Gallbladder cancer who is really cured?
| Autor: | Nicolas Solano, Ivan Roa, Xabier de Aretxabala, M. Vivanco, L. Burgos, Felipe Castillo, J. Hepp, G. Rencoret, Sergio Muñoz |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Poor prognosis
medicine.medical_specialty medicine.medical_treatment Resection 03 medical and health sciences 0302 clinical medicine Humans Medicine Cholecystectomy Gallbladder cancer Lymph node Neoplasm Staging Retrospective Studies R0 resection Surgical team Hepatology business.industry Gastroenterology Prognosis medicine.disease Surgery medicine.anatomical_structure Liver 030220 oncology & carcinogenesis Gallbladder Neoplasms 030211 gastroenterology & hepatology Lymph business |
| Zdroj: | HPB. 23:1253-1258 |
| ISSN: | 1365-182X |
| DOI: | 10.1016/j.hpb.2020.12.006 |
| Popis: | Background Although gallbladder cancer (GBCA) is characterized by a dismal prognosis, there is a proportion of patients who are cured. The aim of this study was to analyze the profile of these patients. Methods A database was queried for patients who underwent curative resection with a follow-up of at least 5 years. Patients were prospectively treated and registered by the same surgical team. A multivariate regression analysis was used to identify factors associated with long-term survival. Results From 1988 to 2013, 461 patients were evaluated and 112 who underwent resection were analyzed. Among the patients, five year survival was 57% while lymph node and liver compromise were the only independent factors associated with survival. On the other hand, the elapsed time between the cholecystectomy and the resection, the differentiation grade and the level of wall invasion did not have an independent effect on the prognosis. Conclusion Despite its poor prognosis, a subset of patients can be cured of GBCA. R0 resection of patients without lymph and liver infiltration are key to GBCA survival. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|